T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alte...
Gespeichert in:
Veröffentlicht in: | Nucleic acids research 2022-01, Vol.50 (D1), p.D883-D887 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | D887 |
---|---|
container_issue | D1 |
container_start_page | D883 |
container_title | Nucleic acids research |
container_volume | 50 |
creator | Nersisyan, Stepan Zhiyanov, Anton Shkurnikov, Maxim Tonevitsky, Alexander |
description | Abstract
Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity. |
doi_str_mv | 10.1093/nar/gkab701 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8385993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/nar/gkab701</oup_id><sourcerecordid>2561926120</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpaTZpT70XnUohuNGXvVYOhWXJR2Gh0KQ99CJG8ihxYluOJAfy7-tktyG99DSHeXjeYV5CPnD2hTMtjwaIR1e3YJeMvyILLitRKF2J12TBJCsLzlS9R_ZTumGMK16qt2RPKqkrqfmC_L4s1uHXMQXqQj9GvMYhtfdIxxAzdDR4er5ZFSOOuW2QtkPGCC63YUgUvEeXsaH2gV6sflw8igpB-ynDE_COvPHQJXy_mwfk5-nJ5fq82Hw_-7ZebQqnuMhFbS0HsLUsEbDkGmTlVOWaZeMVt6qUsNRKcr9sagE1Olta8LbxEoUDjVwekK9b7zjZHhuHQ47QmTG2PcQHE6A1_26G9tpchXtTy7rUWs6CzztBDHcTpmz6NjnsOhgwTMmIsuJaVFywGT3coi6GlCL65xjOzGMbZm7D7NqY6Y8vL3tm_75_Bj5tgTCN_zX9AeuxlXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561926120</pqid></control><display><type>article</type><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</creator><creatorcontrib>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</creatorcontrib><description>Abstract
Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/gkab701</identifier><identifier>PMID: 34396391</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Alleles ; Codon, Terminator ; COVID-19 - immunology ; COVID-19 - virology ; Database Issue ; Databases, Factual ; Epitopes, T-Lymphocyte - immunology ; HLA Antigens - genetics ; HLA Antigens - immunology ; HLA Antigens - metabolism ; HLA-B7 Antigen - immunology ; Host-Pathogen Interactions ; Humans ; India ; Mutation ; SARS-CoV-2 - genetics ; SARS-CoV-2 - pathogenicity ; United Kingdom ; Viral Proteins - genetics ; Viral Proteins - immunology</subject><ispartof>Nucleic acids research, 2022-01, Vol.50 (D1), p.D883-D887</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. 2022</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</citedby><cites>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</cites><orcidid>0000-0002-8830-4679</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385993/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385993/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1604,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34396391$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nersisyan, Stepan</creatorcontrib><creatorcontrib>Zhiyanov, Anton</creatorcontrib><creatorcontrib>Shkurnikov, Maxim</creatorcontrib><creatorcontrib>Tonevitsky, Alexander</creatorcontrib><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>Abstract
Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</description><subject>Alleles</subject><subject>Codon, Terminator</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - virology</subject><subject>Database Issue</subject><subject>Databases, Factual</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>HLA Antigens - genetics</subject><subject>HLA Antigens - immunology</subject><subject>HLA Antigens - metabolism</subject><subject>HLA-B7 Antigen - immunology</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>India</subject><subject>Mutation</subject><subject>SARS-CoV-2 - genetics</subject><subject>SARS-CoV-2 - pathogenicity</subject><subject>United Kingdom</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - immunology</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpaTZpT70XnUohuNGXvVYOhWXJR2Gh0KQ99CJG8ihxYluOJAfy7-tktyG99DSHeXjeYV5CPnD2hTMtjwaIR1e3YJeMvyILLitRKF2J12TBJCsLzlS9R_ZTumGMK16qt2RPKqkrqfmC_L4s1uHXMQXqQj9GvMYhtfdIxxAzdDR4er5ZFSOOuW2QtkPGCC63YUgUvEeXsaH2gV6sflw8igpB-ynDE_COvPHQJXy_mwfk5-nJ5fq82Hw_-7ZebQqnuMhFbS0HsLUsEbDkGmTlVOWaZeMVt6qUsNRKcr9sagE1Olta8LbxEoUDjVwekK9b7zjZHhuHQ47QmTG2PcQHE6A1_26G9tpchXtTy7rUWs6CzztBDHcTpmz6NjnsOhgwTMmIsuJaVFywGT3coi6GlCL65xjOzGMbZm7D7NqY6Y8vL3tm_75_Bj5tgTCN_zX9AeuxlXU</recordid><startdate>20220107</startdate><enddate>20220107</enddate><creator>Nersisyan, Stepan</creator><creator>Zhiyanov, Anton</creator><creator>Shkurnikov, Maxim</creator><creator>Tonevitsky, Alexander</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8830-4679</orcidid></search><sort><creationdate>20220107</creationdate><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><author>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alleles</topic><topic>Codon, Terminator</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - virology</topic><topic>Database Issue</topic><topic>Databases, Factual</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>HLA Antigens - genetics</topic><topic>HLA Antigens - immunology</topic><topic>HLA Antigens - metabolism</topic><topic>HLA-B7 Antigen - immunology</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>India</topic><topic>Mutation</topic><topic>SARS-CoV-2 - genetics</topic><topic>SARS-CoV-2 - pathogenicity</topic><topic>United Kingdom</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nersisyan, Stepan</creatorcontrib><creatorcontrib>Zhiyanov, Anton</creatorcontrib><creatorcontrib>Shkurnikov, Maxim</creatorcontrib><creatorcontrib>Tonevitsky, Alexander</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nersisyan, Stepan</au><au>Zhiyanov, Anton</au><au>Shkurnikov, Maxim</au><au>Tonevitsky, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>2022-01-07</date><risdate>2022</risdate><volume>50</volume><issue>D1</issue><spage>D883</spage><epage>D887</epage><pages>D883-D887</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><abstract>Abstract
Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34396391</pmid><doi>10.1093/nar/gkab701</doi><orcidid>https://orcid.org/0000-0002-8830-4679</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-1048 |
ispartof | Nucleic acids research, 2022-01, Vol.50 (D1), p.D883-D887 |
issn | 0305-1048 1362-4962 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8385993 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Alleles Codon, Terminator COVID-19 - immunology COVID-19 - virology Database Issue Databases, Factual Epitopes, T-Lymphocyte - immunology HLA Antigens - genetics HLA Antigens - immunology HLA Antigens - metabolism HLA-B7 Antigen - immunology Host-Pathogen Interactions Humans India Mutation SARS-CoV-2 - genetics SARS-CoV-2 - pathogenicity United Kingdom Viral Proteins - genetics Viral Proteins - immunology |
title | T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A26%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T-CoV:%20a%20comprehensive%20portal%20of%20HLA-peptide%20interactions%20affected%20by%20SARS-CoV-2%20mutations&rft.jtitle=Nucleic%20acids%20research&rft.au=Nersisyan,%20Stepan&rft.date=2022-01-07&rft.volume=50&rft.issue=D1&rft.spage=D883&rft.epage=D887&rft.pages=D883-D887&rft.issn=0305-1048&rft.eissn=1362-4962&rft_id=info:doi/10.1093/nar/gkab701&rft_dat=%3Cproquest_pubme%3E2561926120%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561926120&rft_id=info:pmid/34396391&rft_oup_id=10.1093/nar/gkab701&rfr_iscdi=true |